• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Theodore S. Hong, MD


  • Wo JY, Childs SK, Szymonifka J, Mamon HJ, Ryan DP, Blaszkowsky LS, Kwak EL, Ferrone CR, Allen JN, Zhu AX, Wolpin BM, Chan JA, Abrams TA, McCleary NJ, Fernandez-Del Castillo C, Hong TS.Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.Practical Radiation Oncology.;4(2):e117-23.
  • Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, Ben-Josef E, Crane CH, Goodman KA, Haddock MG, Herman JM, Hong TS, Kachnic LA, Mamon HJ, Pantarotto JR, Dawson LA.Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus.Practical Radiation Oncology.;4(2):82-9.
  • Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-Del Castillo C, Duda DG.A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreatic Ductal Adenocarcinoma.Int J Radiat Oncol Biol Phys. 2014 May 24.
  • Hong TS, Kwak EL.Adjuvant Therapy for Gastric Cancers: More Answers or More Questions?.Ann Surg Oncol. 2014 May 20.
  • Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, Ferrone CR, Zhu AX, Wo JY, Crane C, Hong TS.Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy.Practical Radiation Oncology.;4(3):167-73.
  • Richter JM, Pino MS, Austin TR, Campbell E, Szymonifka J, Russo AL, Hong TS, Borger D, Iafrate AJ, Chung DC.Genetic Mechanisms in Interval Colon Cancers.Dig Dis Sci. 2014 Apr 5.
  • Borger DR, Goyal L, Yau T, Poon RT, Ancukiewicz M, Deshpande V, Christiani DC, Liebman HM, Yang H, Kim H, Yen K, Faris JE, Iafrate AJ, Kwak EL, Clark JW, Allen JN, Blaszkowsky LS, Murphy JE, Saha SK, Hong TS, Wo JY, Ferrone CR, Tanabe KK, Bardeesy N, Straley KS, Agresta S, Schenkein DP, Ellisen LW, Ryan DP, Zhu AX.Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.Clin Cancer Res. 2014 Apr 1;20(7):1884-90.
  • Chin JY, Pitman MB, Hong TS.Intraductal papillary mucinous neoplasm: clinical surveillance and management decisions.Semin Radiat Oncol. 2014 Apr;24(2):77-84.
  • Wo JY, Mamon HJ, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Tseng YD, Napolitano BN, Ancukiewicz M, Swanson RS, Lillemoe KD, Fernandez-del Castillo C, Hong TS.Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer.Radiother Oncol. 2014 Jan;110(1):160-4.
  • Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ.Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.Dis Colon Rectum. 2014 Apr;57(4):449-59.
  • Russo AL, Ryan DP, Borger DR, Wo JY, Szymonifka J, Liang WY, Kwak EL, Blaszkowsky LS, Clark JW, Allen JN, Zhu AX, Berger DL, Cusack JC, Mamon HJ, Haigis KM, Hong TS.Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer.J Gastrointest Cancer. 2014 Mar;45(1):34-9.
  • Schoenfeld JD, Wo JY, Mamon HJ, Kwak EL, Mullen JT, Enzinger PZ, Blaskowsky LS, Ryan DP, Hong TS.The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation.Am J Clin Oncol. 2014 Feb 26.
  • Wo JY, Dawson LA, Zhu AX, Hong TS.An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Surg Oncol Clin N Am. 2014 Apr;23(2):353-68.
  • , Hong TS, Pretz JL, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Jabbour SK, Jones WE, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Thomas CR, Zook J, Suh WW.ACR Appropriateness Criteria®-Anal Cancer.Gastrointest Cancer Res. 2014 Jan;7(1):4-14.
  • Russo AL, Borger DR, Szymonifka J, Ryan DP, Wo JY, Blaszkowsky LS, Kwak EL, Allen JN, Wadlow RC, Zhu AX, Murphy JE, Faris JE, Dias-Santagata D, Haigis KM, Ellisen LW, Iafrate AJ, Hong TS.Mutational analysis and clinical correlation of metastatic colorectal cancer.Cancer. 2014 Feb 5.
  • Kleiman LB, Krebs AM, Kim SY, Hong TS, Haigis KM.Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers.PLoS ONE. 2013;8(12):e82982.
  • Kim MB, Hong TS, Wo JY.Treatment of stage II-III rectal cancer patients.Curr Oncol Rep. 2014 Jan;16(1):362.
  • Cai S, Hong TS, Goldberg SI, Fernandez-del Castillo C, Thayer SP, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Willett CG, Lillemoe KD, Warshaw AL, Wo JY.Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.Cancer. 2013 Dec 1;119(23):4196-204.
  • Schmidt B, Look-Hong N, Maduekwe UN, Chang K, Hong TS, Kwak EL, Lauwers GY, Rattner DW, Mullen JT, Yoon SS.Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients.Ann Surg Oncol. 2013 Oct;20(11):3512-8.
  • Faris JE, Blaszkowsky LS, McDermott S, Guimaraes AR, Szymonifka J, Huynh MA, Ferrone CR, Wargo JA, Allen JN, Dias LE, Kwak EL, Lillemoe KD, Thayer SP, Murphy JE, Zhu AX, Sahani DV, Wo JY, Clark JW, Fernandez-Del Castillo C, Ryan DP, Hong TS.FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience.Oncologist. 2013 May 8.
  • Pretz JL, Wo JY, Mamon HJ, Kachnic LA, Hong TS.Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer.Surg Oncol Clin N Am. 2013 Jul;22(3):511-24.
  • Yuan Y, Andronesi OC, Bortfeld TR, Richter C, Wolf R, Guimaraes AR, Hong TS, Seco J.Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients.Radiother Oncol. 2013 Mar;106(3):378-82.
  • Hong TS.Radiotherapy for Hepatocellular Carcinoma With Tumor Vascular Thrombus: Ready for Prime Time?.J Clin Oncol. 2013 Apr 1.
  • Lee MS, Mamon HJ, Hong TS, Choi NC, Fidias PM, Kwak EL, Meyerhardt JA, Ryan DP, Bueno R, Donahue DM, Jaklitsch MT, Lanuti M, Rattner DW, Fuchs CS, Enzinger PC.Preoperative cetuximab, irinotecan, Cisplatin, and radiation therapy for patients with locally advanced esophageal cancer.Oncologist. 2013;18(3):281-7.
  • Phillips JG, Hong TS, Ryan DP.Multidisciplinary management of early-stage rectal cancer.J Natl Compr Canc Netw. 2012 Dec 1;10(12):1577-85.
  • Hong TS, Wo JY, Kwak EL.Targeted therapies with chemoradiation in esophageal cancer: development and future directions.Semin Radiat Oncol. 2013 Jan;23(1):31-7.
  • Chin JY, Hong TS, Ryan DP.Mitomycin in Anal Cancer: Still the Standard of Care.J Clin Oncol. 2012 Nov 13.
  • Jones WE, Thomas CR, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Zook J, Suh WW.ACR Appropriateness Criteria®  Resectable Rectal Cancer.Radiat Oncol. 2012;7:161.
  • Wo JY, Hong TS, Kachnic LA.Impact of age and comorbidities on the treatment of gastrointestinal malignancies.Semin Radiat Oncol. 2012 Oct;22(4):311-20.
  • Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Fernandez-Del Castillo C, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR.Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a "True" R0 Resection?.Ann Surg. 2012 Sep 10.
  • Hartman RI, Chang CY, Wo JY, Eisenberg JD, Hong TS, Harisinghani MG, Gazelle GS, Pandharipande PV.Optimizing Adjuvant Treatment Decisions for Stage T2 Rectal Cancer Based on Mesorectal Node Size: A Decision Analysis.Acad Radiol. 2012 Sep 1.
  • Hallman JL, Mori S, Sharp GC, Lu HM, Hong TS, Chen GT.A Four-Dimensional Computed Tomography Analysis of Multiorgan Abdominal Motion.Int J Radiat Oncol Biol Phys. 2011 Dec 22.
  • Adkison JB, McHaffie DR, Bentzen SM, Patel RR, Khuntia D, Petereit DG, Hong TS, Tomé W, Ritter MA.Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):184-90.
  • Craft DL, Hong TS, Shih HA, Bortfeld TR.Improved planning time and plan quality through multicriteria optimization for intensity-modulated radiotherapy.Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e83-90.
  • Knopf AC, Hong TS, Lomax A.Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics.Phys Med Biol. 2011 Nov 21;56(22):7257-71.
  • Arvold ND, Ryan DP, Niemierko A, Blaszkowsky LS, Kwak EL, Wo JY, Allen JN, Clark JW, Wadlow RC, Zhu AX, Fernandez-Del Castillo C, Hong TS.Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.Cancer. 2011 Oct 21.
  • Margalit DN, Mamon HJ, Ancukiewicz M, Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG, Hong TS.Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older.Int J Radiat Oncol Biol Phys. 2011 Mar 4.
  • Engelsman M, Delaney TF, Hong TS.Proton Radiotherapy: The Biological Effect of Treating Alternating Subsets of Fields for Different Treatment Fractions.Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):616-22.
  • Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Kwak EL, Mino-Kenudson M, Adams J, Yeap B, Winrich B, Delaney TF, Fernandez-Del Castillo C.Phase I Study of Preoperative Short-Course Chemoradiation with Proton Beam Therapy and Capecitabine for Resectable Pancreatic Ductal Adenocarcinoma of the Head.Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):151-7.
  • Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, Willins JD, Ryan DP, Hong TS.Dose-painted Intensity-modulated Radiation Therapy for Anal Cancer: A Multi-institutional Report of Acute Toxicity and Response to Therapy.Int J Radiat Oncol Biol Phys. 2010 Nov 20.
  • Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE.Adoption of Preoperative Radiation Therapy for Rectal Cancer From 2000 to 2006: A Surveillance, Epidemiology, and End Results Patterns-of-Care Study.Int J Radiat Oncol Biol Phys. 2010 Oct 18.
  • Klos CL, Shellito PC, Rattner DW, Hodin RA, Cusack JC, Bordeianou L, Sylla P, Hong TS, Blaszkowsky L, Ryan DP, Lauwers GY, Chang Y, Berger DL.The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery.Am J Surg. 2010 Oct;200(4):440-5.
  • Arvold ND, Niemierko A, Mamon HJ, Fernandez-Del Castillo C, Hong TS.Pancreatic Cancer Tumor Size on CT Scan Versus Pathologic Specimen: Implications for Radiation Treatment Planning.Int J Radiat Oncol Biol Phys. 2010 Aug 12.
  • Miyamoto DT, Mamon HJ, Ryan DP, Willett CG, Ancukiewicz M, Kobayashi WK, Blaszkowsky L, Castillo CF, Hong TS.Outcomes and Tolerability of Chemoradiation Therapy for Pancreatic Cancer Patients Aged 75 Years or Older.Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1171-7.
  • Chen RC, Mamon HJ, Chen YH, Gelman RS, Suh WW, Talcott JA, Clark JW, Hong TS.Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer.Cancer. 2010 Apr 15;116(8):1879-86.